Predictive Positive Value Xpert MTB/RIF in Detecting Mycobacterium tuberculosis on Adult Pulmonary Tuberculosis Patients in Dr. Soetomo Referral Hospital Surabaya Indonesia
Downloads
Pulmonary tuberculosis is an infectious disease caused by Mycobacterium tuberculosis (Mtb) and transmitted via droplets. Southeast Asia is the largest contributor of TB, and Indonesia itself has the second-highest number in the world with an incidence of approximately 824000 cases. The most common symptoms of active TB are cough, fever, weight loss, and night sweats. The diagnosis can be established upon the confirmation that one of the specimens contains M. tuberculosis. Xpert MTB/RIF provides results in less than 2 hours, whereas culture takes approximately 2-6 weeks. This research aims to evaluate the characteristics and determine the Predictive Positive Value (PPV) percentage of GeneXpert MTB/RIF, utilizing parameters derived from the gold standard examination results, namely culture. This research method is descriptive- analytic based on secondary data extracted from medical records of patients receiving care at the multi-drug resistant TB (MDR-TB) Outpatient Management at Dr. Soetomo Referral Hospital Surabaya from the period January 2019 – April 2022. The results showed that the PPV level of GeneXpert MTB/RIF in detecting the presence of M. tuberculosis is 90%. The diagnosis of pulmonary TB is also supported by the chest X-ray infiltrate's appearance and clinical symptoms of cough, weight loss, fever, and night sweats. Smoking and diabetes are the most common comorbid and risk factors in TB. The conclusion of this study is that the PPV for diagnosing adult pulmonary TB using the Xpert MTB/RIF is relatively high. This suggests the potential use of this method as a diagnosing tool for accurately diagnosing pulmonary tuberculosis.
Centers for Disease Control and Prevention. Core Curriculum on Tuberculosis: What the Clinician Should Know. 2021.
Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk Factors for Tuberculosis. Pulm Med. 2013; 2013:1–11.
World Health Organization. GLOBAL TUBERCULOSIS REPORT 2021 [Internet]. 2021. Available from: http://apps.who.int/bookorders.
KEMENKES RI. KEMENTERIAN KESEHATAN REPUBLIK INDONESIA. 2019. Available from: https://repository.kemkes.go.id/book/124
Rarome BB, Aisah N, Setyoningrum RA, Mertaniasih NM. GeneXpert MTB/RIF and Mycobacterium tuberculosis Sputum Culture in Establishing the Diagnosis of Pulmonary Tuberculosis and Rifampicin Resistance in Suspected Childhood Pulmonary Tuberculosis in Soetomo Hospital. Indonesian J. Tropical Infectious Disease. 2020 Dec 3; 8(3):152.
Susilawati TN, Larasati R. A recent update of the diagnostic methods for tuberculosis and their applicability in Indonesia: a narrative review. Med J Indones. 2019 Oct 4; 28(3):284–91.
Das A, Anupurba S, Mishra OP, Banerjee T, Tripathi R. Evaluation of Xpert MTB/RIF Assay for Diagnosis of Tuberculosis in Children. J Trop Pediatr. 2019 Feb 1; 65(1):14–20.
Horne DJ, Kohli M, Zifodya JS, Schiller I, Dendukuri N, Tollefson D, et al. Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database of Systematic Reviews. 2019 Jun 7;
Opota O, Mazza-Stalder J, Greub G, Jaton K. The rapid molecular test Xpert MTB/RIF ultra: towards improved tuberculosis diagnosis and rifampicin resistance detection. Clin Microbiol Infect. 2019 Nov; 25(11):1370–6.
Permatasari S, Vrenika V, Felicia F, Malasinta M, Eriani R, Saraswati NP, et al. Validitas Metode Real Time PCR GeneXpert pada Suspek TB Paru BTA Negatif di RSUD Dr. Doris Sylvanus. Jurnal Surya Medika. 2021 Aug 30;7(1):88–93.
Afsar I, Gunes M, Er H, Gamze Sener A. Comparison of culture, microscopic smear and molecular methods in diagnosis of tuberculosis. Rev Esp Quimioter. 2018 Oct;31(5):435–8.
Arnett JJ, ŽukauskienÄ— R, Sugimura K. The new life stage of emerging adulthood at ages 18–29 years: implications for mental health. Lancet Psychiatry. 2014 Dec;1(7):569–76.
World Health Organization. Global tuberculosis report 2023 [Internet]. 2023 [cited 2023 Nov 30]. Available from: https://iris.who.int/bitstream/handle/10665/373828/9789240083851-eng.pdf?sequence=1
Dong Z, Wang QQ, Yu SC, Huang F, Liu JJ, Yao HY, et al. Age–period–cohort analysis of pulmonary tuberculosis reported incidence, China, 2006–2020. Infect Dis Poverty. 2022 Dec 28; 11(1):85.
Marçí´a R, Ribeiro AI, Zí£o I, Duarte R. Tuberculosis and gender – Factors influencing the risk of tuberculosis among men and women by age group. Pulmonology. 2018 May; 24(3):199–202.
Uys P, Brand H, Warren R, van der Spuy G, Hoal EG, van Helden PD. The Risk of Tuberculosis Reinfection Soon after Cure of a First Disease Episode Is Extremely High in a Hyperendemic Community. PLoS One. 2015 Dec 9; 10(12):e0144487.
Nowiński A, Wesołowski S, Korzeniewska-Koseła M. The impact of comorbidities on tuberculosis treatment outcomes in Poland: a national cohort study. Front Public Health. 2023 Sep 5; 11.
Restrepo BI. Diabetes and Tuberculosis. Microbiol Spectr. 2016 Dec 23;4(6).
Silva DR, Muñoz-Torrico M, Duarte R, Galví£o T, Bonini EH, Arbex FF, et al. Risk factors for tuberculosis: diabetes, smoking, alcohol use, and the use of other drugs. J Bras Pneumol. 2018 Apr; 44(2):145–52.
Krishna S, Jacob JJ. Diabetes Mellitus and Tuberculosis. 2021.
Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV Coinfection: Table 1. Cold Spring Harb Perspect Med. 2015 Jul; 5(7):a017871.
Imtiaz S, Shield KD, Roerecke M, Samokhvalov A V, Lönnroth K, Rehm J. Alcohol consumption as a risk factor for tuberculosis: meta-analyses and burden of disease. Eur Respir J. 2017 Jul; 50(1).
Verma D, Bose C, Tufchi N, Pant K, Tripathi V, Thapliyal A. An efficient framework for identification of Tuberculosis and Pneumonia in chest X-ray images using Neural Network. Procedia Comput Sci. 2020; 171:217–24.
Pinto LM, Pai M, Dheda K, Schwartzman K, Menzies D, Steingart KR. Scoring systems using chest radiographic features for the diagnosis of pulmonary tuberculosis in adults: a systematic review. Eur Respir J.2013 Aug; 42(2):480–94.
Turner RD, Bothamley GH. Cough and the Transmission of Tuberculosis. J Infect Dis. 2015 May; 211(9):1367–72.
Ye M, Bian LF. Association of serum leptin levels and pulmonary tuberculosis: a meta-analysis. J Thorac Dis. 2018 Feb; 10(2):1027–36.
Luies L, du Preez I. The Echo of Pulmonary Tuberculosis: Mechanisms of Clinical Symptoms and Other Disease-Induced Systemic Complications. Clin Microbiol Rev. 2020 Sep 16; 33(4).
Safari S, Baratloo A, Elfil M, Negida A. Evidence Based Emergency Medicine Part 2: Positive and negative predictive values of diagnostic tests. Emerg (Tehran). 2015; 3(3):87–8.
Geleta DA, Megerssa YC, Gudeta AN, Akalu GT, Debele MT, Tulu KD. Xpert MTB/RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility. BMC Microbiol. 2015 Dec 19; 15(1):220.
Theron G, Venter R, Calligaro G, Smith L, Limberis J, Meldau R, et al. Xpert MTB/RIF Results in Patients With Previous Tuberculosis: Can We Distinguish True From False Positive Results? Clinical Infectious Diseases. 2016 Apr 15; 62(8):995–1001.
Allahyartorkaman M, Mirsaeidi M, Hamzehloo G, Amini S, Zakiloo M, Nasiri MJ. Low diagnostic accuracy of Xpert MTB/RIF assay for extrapulmonary tuberculosis: A multicenter surveillance. Sci Rep. 2019 Dec 6; 9(1):18515.
Kwak N, Choi SM, Lee J, Park YS, Lee CH, Lee SM, et al. Diagnostic Accuracy and Turnaround Time of the Xpert MTB/RIF Assay in Routine Clinical Practice. PLoS One. 2013 Oct 29; 8(10):e77456.
Copyright (c) 2024 Indonesian Journal of Tropical and Infectious Disease
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Indonesian Journal of Tropical and Infectious Disease (IJTID) is a scientific peer-reviewed journal freely available to be accessed, downloaded, and used for research. All articles published in the IJTID are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License, which is under the following terms:
Attribution ” You must give appropriate credit, link to the license, and indicate if changes were made. You may do so reasonably, but not in any way that suggests the licensor endorses you or your use.
NonCommercial ” You may not use the material for commercial purposes.
ShareAlike ” If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
No additional restrictions ” You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
